Inhalatives Pragmatism IEC Informed Consent Procedure Product development Training Consultancy Ophthalmological trials Pituitary Ophthalmology Network Patch Metered dose inhaler Clinical Monitoring Dose linearity MDI CRA Creativity SOP based CDASH ADAM Uveitis PASS Female adolescents SAS IMPD MCID Standardisation Investigators brochure Sample size estimation Hormone replacement therapy Standard operating procedure ANVISA Transdermal therapeutic system Sore throat Efficacy Drug Food Interaction Absorption windows Sequential designs Patients Children AGAH Asthma Axis Project Management Statistical services Anaesthesiologist Quality Postmenopausal women COPD Statistical programming Statistical Analysis Plan Scientific expertise Common cold Contraception Post authorisation Patch adhesion CDISC GCP training Legal representative Biometrics Phase IV Biopharmaceutical Non interventional Absorption Hypothalamic Edema Competence Local tolerability Pulse oximetry plethysmography Dry eye Clinical development program Paediatricians US CFR 21 Part 11 Phase III CDSIC Legal Information Rhine Main area NIS Spacious archive Oncology DFI Good Clinical Practice HTA Expert Charcoal Phase I Subcontractor qualification Pharmacodynamic studies Dermal irritation Highly variable drugs WinNonlin TTS Macular Gynaecological trials Database DPI CRO FDA IVIVC Audit Oncologic network Centralised procedure Pharmacokintetics Clinical study Healthy subjects Biopharmaceutics Recruitment rates Authorities Drug Drug Interaction Early phase MMM Pharmacokinetics First in human Elpro Bioequivalence CDM Sensitisation trials Pilot study Protocol development Protocol Eye disease US FDA Pharmacology Intensive assessment station DDI Life cycle management GCP Data Management Plan Auditing Inspection Safety CRF Experience Phase II Phase IIa trials ICF Immunogenicity Steady state Cardiovascular surveillance In vitro in vivo correlation Patient recruitment DUS Lung Endpoint Scientific advice Design development IB FIM Clinical trials Slit lamp microscopy Dry powder inhaler OTC Data management HPA axis Clinical pharmacology unit Allergy Ocular tolerability Phase I Unit Degeneration Ovulation inhibition Copyright Thuringia Feasibility Phase IIb trials Cough Adrenocortical HRT Source Data Verification SocraTec C&S PAES SDV Glaucoma Bioavailability EMA Quality Management System Xerostomia Central surveillance system Ophthalmologist Biosimilars GLP Oncological patients Referral system Monitoring Data Validation Plan Quality Assurance
Box 0
Design Development
Box 1
Scientific Advice
Box 2
Project Management
Box 3
Quality Assurance (QA)
Box 4
Box 5
Clinical Performance
Box 6
Data Management / eTrials
Box 7
Box 8
Medical Writing
Box 9
Expert Statement
Box 10
Box 11
Box 12
Bioavailability / Bioequivalence
Box 13
Box 14
Oncological trials
Box 15
Ophthalmological trials
Box 16
Box 17
Transdermal Therapeutic Systems
Box 18
Box 19
Sexual Hormones
Box 20
Therapeutic Expertise
Box 21
Clinical Development
Box 22
Phase I
Box 23
Phase II / Proof of Concept
Box 24
Phase III in OTC
Box 25
Phase III
Box 26
Box 27
Magnetic Marker Monitoring
Box 28
Medical Devices
Box 29
Nutrition Studies
Box 30
Clinical Pharmacology Unit
Box 31
Location Plan
Box 32
Box 33
Technical Monitoring
Box 34
Box 35
Box 36
Intensive Assessment Unit
Box 37
Clean Room Area
Box 38
Box 39
About Us
Box 40
Goals and Visions
Box 41
Our Experts
Box 42
Box 43
Box 44
Library Presentations
Box 45
Library Publications
Box 46
Box 47
Box 48
Box 49
Introductory Course in Exploratory Medicines ...
Box 50
2nd Global Bioequivalence Harmonisation Initi...
Box 51
Quality Management Systems in Early Phase Tri...
Box 52
Trial in drug-induced xerostomia published
Box 53
2nd Global Bioequivalence Harmonisation Initi...
Box 54
Routine GCP inspection successfully passed
Box 55
Box 56
The SocraTec Family
Box 57
SocraTec C&S
Box 58
Box 59
Box 60

All fine on front page